S. Delany-Moretlwe
University of the Witwatersrand
South Africa
About
No AI summary yet.
Metrics
- Publications
- 236
- Citations
- 8.9K
- h-index
- 49
- Publishing journals
- 79
- Years of publications
- 20+
- Active since
- 2007
- References
- 9.3K
- Institutions
- 11
Publication history
Latest publications
- Population impact of South Africa's human papillomavirus (HPV) vaccination programme on HPV prevalence in adolescent girls with and without HIV: a repeat cross-sectional study.
- The influence of stigma on PrEP uptake among adolescent girls and young women in Johannesburg, South Africa and Mwanza, Tanzania: Qualitative findings from the EMPOWER study.
- Safety, tolerability, and acceptability of long-acting injectable cabotegravir for HIV prevention in cisgender female adolescents (HPTN 084-01): a single-arm, open-label, phase 2b trial
- The effect of STI screening during pregnancy on vertical transmission of HIV and adverse pregnancy outcomes in South Africa: a modelling study
- High prevalence and incidence of curable sexually transmitted infections among young women using oral HIV pre-exposure prophylaxis in sub-Saharan Africa: results from the INSIGHT Cohort study.
- The impact of HIV on cervical cancer elimination in Kwazulu-Natal: a comparative modeling analysis.
- Evaluation of pharmacokinetic interactions between long‐acting cabotegravir or emtricitabine/tenofovir disoproxil fumarate and hormonal contraceptive agents: a tertiary analysis of South African participants in HPTN 084
- Preferences for HIV pre‐exposure prophylaxis formulations and delivery among young African women: results of a discrete choice experiment
- Combining HIV prevention Options with Mental health service delivery for Adolescent girls and young women (CHOMA): results of a pilot hybrid effectiveness‐implementation randomized trial in South Africa
- Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women
- Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis
- Evaluation of long-acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084.
- The potential benefits of long-acting injectable cabotegravir in pregnant and breastfeeding women and their infants
- Long-acting cabotegravir pharmacokinetics with and without oral lead-in for HIV PrEP
- High recent PrEP adherence with point‐of‐care urine tenofovir testing and adherence counselling among young African women: results from the INSIGHT cohort
- Vaccine value profile for herpes simplex virus
- Generalizing the Intention-to-Treat Effect of an Active Control from Historical Placebo-Controlled Trials: A Case Study of the Efficacy of Daily Oral TDF/FTC in the HPTN 084 Study
- Integrating a mental health intervention into PrEP services for South African young women: a human‐centred implementation research approach to intervention development
- Impact of single-dose HPV vaccination on HPV 16 and 18 prevalence in South African adolescent girls with and without HIV
- High prevalence of human papillomavirus (HPV) in unvaccinated adolescent girls in South Africa, particularly those living with HIV
No publications in the index yet.